Fujian Cosunter Pharmaceutical Co., Ltd. (SHE:300436)

Market Cap	13.99B +189.2%
Revenue (ttm)	417.21M -0.4%
Net Income	-215.28M
EPS	n/a
Shares Out	159.27M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,746,843
Open	97.61
Previous Close	85.78
Day's Range	84.60 - 97.61
52-Week Range	32.52 - 188.93
Beta	1.14
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About SHE:300436

Fujian Cosunter Pharmaceutical Co., Ltd. engages in the research and development, manufacture, and sale of pharmaceutical products in China. It offers drugs for anti-HBV, liver diseases, hepatobiliary disease drugs, metabolism and digestive system, respiratory, cardiovascular, men’s health, and other fields. Fujian Cosunter Pharmaceutical Co., Ltd. was founded in 2001 and is headquartered in Fuzhou, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2001
• Employees: 715
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 300436

Financial Performance

In 2025, SHE:300436's revenue was 416.37 million, a decrease of -5.68% compared to the previous year's 441.46 million. Losses were -217.85 million, 39.4% more than in 2024.